NIMG-57 QUANTITATION OF 18F-DOPA UPTAKE ON PET PREDICTS TUMOR GRADE WITH HIGH SENSITIVITY AND SPECIFICITY IN NEWLY-DIAGNOSED GLIOMA: UCLA EXPERIENCE

Por Patel, Chirag, Nguyen, Huytram, Manoukian, Jasmine, Ellingson, Benjamin, Czernin, Johannes, Cloughesy, Timothy, Nghiemphu, Phioanh, Lai, Albert
Publicado no Neuro Oncol (2015)

NCMP-01. SEIZURE CONTROL AFTER INITIAL PRESENTATION IN IDH MUTATED GLIOMA PATIENTS

Por Ozer, Byram, Bui, Yvonne, Markovic, Daniela, Nguyen, Huytram, Liau, Linda, Nghiemphu, Phioanh, Cloughesy, Timothy, Lai, Albert
Publicado no Neuro Oncol (2017)

Quantification of nonenhancing tumor burden in gliomas using effective T(2) maps derived from dual echo turbo spin echo MRI

Por Ellingson, Benjamin M., Lai, Albert, Nguyen, Huytram N., Nghiemphu, Phioanh L., Pope, Whitney B., Cloughesy, Timothy F.
Publicado no Clin Cancer Res (2015)

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

Por Rapkins, Robert W., Wang, Fan, Nguyen, HuyTram N., Cloughesy, Timothy F., Lai, Albert, Ha, Wendy, Nowak, Anna K., Hitchins, Megan P., McDonald, Kerrie L.
Publicado no Neuro Oncol (2015)

ACTR-53. SAFETY AND EFFICACY EVALUATION OF A PHASE II STUDY OF BORTEZOMIB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEW...

Por Kong, Xiao-Tang, Nguyen, Nhung, Choi, Yoon, Zhang, Guicheng, Nguyen, Huytram, Filka, Emese, Green, Stacy, Yong, William, Liau, Linda, Kaprealian, Tania, Pope, Whitney, Nghiemphu, Phioanh, Cloughesy, Timothy, Lassman, Andrew, Lai, Albert
Publicado no Neuro Oncol (2017)

EPIG-11 THE IMPLICATION OF CpG island AND SPINT2 HYPERMETHYLATION IN BOTH IDH1 WILD-TYPE AND MUTANT ADULT DIFFUSE GLIOMAS

Por Liu, Fei, Chowdhury, Reshmi, Li, Tie, Li, Sichen, Nguyen, Huytram, Wei, Bowen, Chou, Arthur P., Reiss, Jean K., Mody, Reema R., Liau, Linda M., Nghiemphu, Phioanh L., Yong, William H., Cloughesy, Timothy, Lai, Albert
Publicado no Neuro Oncol (2015)

D-2-Hydroxyglutarate is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-induced MIR148A Promoter Methylation

Por Li, Tie, Cox, Christopher D., Ozer, Byram H., Nguyen, Nhung T., Nguyen, HuyTram N., Lai, Thomas J., Li, Sichen, Liu, Fei, Kornblum, Harley I., Liau, Linda M., Nghiemphu, Phioanh L., Cloughesy, Timothy F., Lai, Albert
Publicado no Mol Cancer Res (2018)

Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy

Por Nguyen, HuyTram N., Lie, Amy, Li, Tie, Chowdhury, Reshmi, Liu, Fei, Ozer, Byram, Wei, Bowen, Green, Richard M., Ellingson, Benjamin M., Wang, He-jing, Elashoff, Robert, Liau, Linda M., Yong, William H., Nghiemphu, Phioanh L., Cloughesy, Timothy, Lai, Albert
Publicado no Neuro Oncol (2017)